Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.
因此,我么你建议,在开始接受秋水仙碱治疗效果不明显转而接受氨苯砜治疗的患者应当继续服用秋水仙碱。
Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.
因此,我么你建议,在开始接受秋水仙碱治疗效果不明显转而接受氨苯砜治疗的患者应当继续服用秋水仙碱。
声明:以、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.
因此,我么你建议,在开始接受秋水仙碱治疗效果不明显转而接受氨苯砜治疗的患者应当继续服用秋水仙碱。
声明:以上例句、词类均由互联网资源自动生成,部
未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.
因此,我么你建议,在开始接受秋水仙碱治效果不明显转而接受
治
的患者应当继续服用秋水仙碱。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.
因此,我么你建议,在开始接受秋水仙碱治疗效果不显转而接受
苯砜治疗的患者应当继续服用秋水仙碱。
声:
例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.
因此,我么你建议,在开始接受秋水仙碱治疗效果不明显转而接受氨苯砜治疗的患者应当继续服用秋水仙碱。
声明:句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.
因此,我么你建议,在开始接受秋水仙碱治疗效果不明显转而接受氨苯砜治疗的患者应当继续服用秋水仙碱。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.
因此,我么你建议,在开始接受仙碱治疗效果不明显转而接受
砜治疗的患者应当继续服
仙碱。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.
因此,建议,在开始接受秋水仙碱治疗效果不明显转而接受
苯砜治疗的患者应当继续服用秋水仙碱。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向们指正。
Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.
因此,我么你建议,在开始接受仙碱治疗效果不明显转而接受
砜治疗的患者应当继续服
仙碱。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.
因此,我么你建议,在开始接受秋治疗效果不明显转而接受氨苯砜治疗的患者应当继续服用秋
。
声明:以上例句、词性分类均由互网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。